Hi YesSir. I've actually been considering this too. If I were looking to partner and looking for the lowest hanging fruit I'd consider a therapeutic HPV vaccine seriously. I'm not 100% sure on the details, but if there were a fast track option for a vaccine similar to Gardasil, I might be inclined to say I'm not interested in HSV, but in HPV.
I'm speculating wildly here.
Ann: HSV-2 Phase IIa Results Investor Webinar, page-138
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |